Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

NCT07505069 is registered in ClinicalTrials.gov with Nanolattix Biotechnology Co., Ltd. as lead sponsor.

NCT NCT07505069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07505069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors
Lead sponsor
Nanolattix Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
January 29, 2026
Completion date
February 28, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors